Profile
PLRZ VRTX REGN VRNA ARGX ALNY
Company Name Polyrizon Ltd. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $13.38M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Tomer Izraeli Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
PLRZ VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
PLRZ VRTX REGN VRNA ARGX ALNY
Last Close $0.7243 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.04 $513.76 $788 $106.91 $929.61 $491.09
Low 52 - $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -76.17 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
PLRZ VRTX REGN VRNA ARGX ALNY
1 Month Return -31.35 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -29.68 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 10874.2 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -30.96 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -66.62 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -27.57 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PLRZ VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
PLRZ VRTX REGN VRNA ARGX ALNY
Asset Growth 892.31 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -2850 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -142.83 % 9.09 % -131.37 % 24.59 %
Net Income Growth -157.5 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share - 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share - 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share - 680.22 % -35.51 % 55.09 %
Operating Income Growth -105.04 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -113.59 % - -143.33 % -107.98 %
Operating 3 Year CFG - -100 % -170.73 % 98.8 %
Operating 5 Year CFG - -100 % 54.81 % 97.44 %
Operating 10 Year CFG - -100 % 40.15 % 97.08 %
EPS Growth - 5.31 % -214.81 % 38.07 %
EPS Diluted Growth - 8.19 % -208.93 % 38.07 %
Book Value Per Share - 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share - 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share - 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share - 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -100 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -113.59 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
PLRZ VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -5.11 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -8.09 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 0.02 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 84449.34 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM -32.97 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.56 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.56 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 1096.88 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -16.47 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -22.82 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -22.82 32.86 16.23 -126.33 144.41 162.25
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.61
AARD Aardvark Therapeutics, Inc. Common Stock 13.48
ABCL AbCellera Biologics Inc. 3.22
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.48
ABPWW 0.0155
ABSI Absci Corporation 2.76
ABUS Arbutus Biopharma Corporation 4.05
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 119.78
ACAD ACADIA Pharmaceuticals Inc. 23.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.25
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.33
ACIU AC Immune SA 3.11
Unlock